Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Blake Dodge"


25 mentions found


Zus Health launched in 2021 with $34 million from investors including Andreessen Horowitz, F-Prime Capital, Maverick Ventures, and Rock Health. Bush, Zus' CEO, told investors in a pitch, per a video Bush sent to Insider. Bush told Insider he was "blessed" to have his stake in the company diluted in this fashion, given the funding climate. "There's all these little pieces, but all of them are just re-clipboarding because nobody has a common clinical story," Bush told investors. Here's the deck Zus used to raise $40 million from Andreessen Horowitz, F-Prime Capital, Maverick Ventures, and Jazz Venture Partners.
Zus Health, his new startup, aims to continue some of his work at Athena to digitize patient health. Zus Health launched in 2021 with $34 million from investors including Andreessen Horowitz, F-Prime Capital, Maverick Ventures, and Rock Health. Bush, Zus' CEO, told investors in a pitch, per a video Bush sent to Insider. Bush told Insider he was "blessed" to have his stake in the company diluted in this fashion, given the funding climate. "There's all these little pieces, but all of them are just re-clipboarding because nobody has a common clinical story," Bush told investors.
Yakubchyk told Insider that the venture studio is separate from Elemy and that he's only passively involved in it. Now they have to email a help desk, which takes longer and is less helpful, three behavior analysts said. Yakubchyk told Insider, however, that the company is still in the early stages of finding the right model for the long term. In the meeting, Tim Eby, Elemy's president, told analysts that running their own businesses would offer them more "empowerment." At Elemy, clinicians who leave largely aren't being replaced because everyone in clinical recruiting has been laid off.
Cerebral plans to cut 15% of its staff, or 285 employees, Insider has learned. Cerebral has been struggling to stay afloat following scrutiny of its prescription practices. Mental-health startup Cerebral is laying off 15% of its workforce, or about 285 employees, as the company reels from a tumultuous year of public scrutiny and federal investigations into its prescribing practices. Impacted employees will be notified through March 1, per Mou's email to Cerebral staff. Cerebral's rocky futureIn 2021, Cerebral called itself the fastest-growing mental-health company.
It's getting harder for digital-health startups to get investor attention. Fewer digital-health startups are fundraising, and the ones that are will be held to higher standards than before, investors told Insider. This year, a smaller group of digital-health startups is beginning to stand out. "It's been amazing to watch what this business has accomplished," she told Insider. Quantum is already earning enough to fund itself, Zane Burke, the CEO of Quantum, told Insider.
NOCD in January raised $34 million as digital-health funding tumbles. In a brutal time to raise money from investors, the mental-health startup NOCD, which provides care for people with obsessive-compulsive disorder, just raised $34 million. Cigna Ventures, the health-insurance giant's venture-capital arm, and 7wireVentures, a prominent healthtech venture-capital firm, co-led the round, bringing NOCD's total funding to $84 million. NOCD shared with Insider the presentation that helped it land $34 million from Cigna Ventures and 7wireVentures. Here's the deck NOCD used to raise $34 million from top investors.
Analysts and CEOs told Insider more than half of healthcare startups will shut down by 2024. Healthcare startups looking to stay afloat have been laying off employees left and right. The online pharmacy Truepill burned through its cash as it struggled to fill prescriptions efficiently, two former employees told Insider. A spokesperson for Truepill told Insider in an email that the company's burn rate was in line with its projections. Courtesy NOCDWhile the broader economic pressures will hurt many startups that can't raise, it may help others, experts told Insider.
It's focused on providing primary care and dispensing prescriptions through Amazon Pharmacy. It hasn't been smooth sailing, and the tech giant has shut down some projects. It hasn't been smooth sailing for every healthcare project. In August, it shut down Amazon Care, a big homegrown primary-care bet. Analysts think in 2023 Amazon will continue to build on its healthcare business through more acquisitions.
Mark Cuban has invested in the online pharmacy Truepill, he confirmed to Insider. It works with Cuban's other healthcare bet Mark Cuban Cost Plus Drug Co.Mark Cuban's interest in breaking into the healthcare industry is heating up. In November, he backed the online pharmacy Truepill through its funding round, Cuban confirmed to Insider in an email. He's played an active role in his drug-pricing startup, which launched as the Mark Cuban Cost Plus Drug Co. in 2021. When asked about the delays, Cuban said Cost Plus Drugs' volume exceeded both companies' expectations.
Biopharma CEOs say his company Cost Plus Drugs could remove costs from the distribution system. Cuban told Insider in an email that he believed the company's pricing transparency was "an absolute positive for patients." The company started its pharmacy services last year and quickly racked up over 1 million accounts, Cuban told Insider recently. Cost Plus Drugs is focused on bringing down the price of generic medications, which no longer have patent protections but can still be expensive. Cuban told Insider that EQRx was in a "different business" than what he's attempting to build out.
Mark Cuban has invested in the online pharmacy Truepill, he confirmed to Insider. Truepill works with healthcare startups to send medications through the mail. It works with Cuban's other healthcare bet Mark Cuban Cost Plus Drug Co.Mark Cuban's interest in breaking into the healthcare industry is heating up. In November, he backed the online pharmacy Truepill through its funding round, Cuban confirmed to Insider in an email. He's played an active role in his drug-pricing startup, which launched as the Mark Cuban Cost Plus Drug Co. in 2021.
Carbon Health on Monday landed $100 million from CVS Health as digital-health funding slows. Its CEO, Eren Bali, said it took a valuation hit to get clean terms for its long-term success. In digital health's dismal funding market, Carbon Health just notched a big win. The startup, which operates clinics offering urgent and primary care, announced on Monday that it snagged $100 million in Series D funding from CVS Health Ventures. The pharmacy giant also said it would open Carbon Health clinics at some CVS Health locations.
Many digital-health startups enjoy tech valuations without differentiated technology. As record investment has flowed into care startups, many of them have enjoyed valuations that mirror those of tech companies. In 2023, thanks in part to the struggling economy, Ho predicts that digital-health investing will stop rewarding this approach and favor startups with true technology differentiation. Ho said it's the right time for real technology startups to take off in healthcare. She's looking for founding teams with three distinct superpowers: understanding the healthcare landscape, understanding the technology behind products, and understanding that technology's clinical application.
He predicted a wave of consolidation in digital health due to the economic downturn. He also said a big tech or retail company may be interested in a healthcare purchase. The market volatility has made it harder to predict healthcare startups' financial futures and valuations, critical components of M&A, he told Insider. As for what type of healthcare companies tech firms will actually acquire, Gregory said it could be those that sell health records, primary care, or Medicare Advantage plans. Missy Krasner, a top digital health investor, echoed this prediction to Insider, saying that Alphabet, Salesforce, or Amazon could move to acquire a company that has patient health records.
She said that next year, a tech giant will buy an electronic medical records company. Missy Krasner, who oversaw several health efforts at Google and Amazon, predicts that a large technology firm will buy a mountain of patient medical records in 2023. EHR companies provide software that doctors use to store and analyze medical records and other kinds of patient data. The timing is right for big tech to make a play for patient dataThe timing may be right for a big tech company to buy its way into owning patient data. Tech companies have made seismic investments in this area.
It called itself the fastest-growing mental-health company. Some Cerebral clinicians told Insider they were uncomfortable treating the patients assigned to them and felt their licenses were at risk. In the past few years, highly funded startups have tried to disrupt mental-health care and struggled. Cerebral's next steps will dictate its future, and its story could influence what's ahead for online mental-health care. A former Cerebral provider told Insider the ban was frustrating because many patients who were improving on the drugs lost access to care at Cerebral.
Funding raised: $27 millionNumber of employees: 20Why it's set to take off next year: Provider burnout is getting worse, and it's exacerbating healthcare's staffing crisis. Nof said he expected Abridge's technology to be in demand next year as hospitals worked to reduce the administrative burdens on doctors. "They've reached a tipping point where people are desperate to gain efficiencies in their workday with all the physician burnout," he said. Abridge's technology takes the audio from doctor-patient interactions and automatically turns it into documentation for billing purposes or a summary of the visit for the patient. That means doctors are relieved of the "hours of pajama time in the evening that they previously spent doing clinical documentation," Cheatham said.
The agency alleges that the pharmacy startup unlawfully dispensed stimulants used to treat ADHD. Truepill partnered with the mental-health startup Cerebral to send prescriptions to its patients. The Order to Show Cause requires that Truepill show evidence to justify its prescribing practices for controlled substances, which are highly regulated drugs. If the evidence isn't convincing, the pharmacy startup could have its DEA license revoked, which would leave the company unable to fill prescriptions for controlled substances. In "numerous instances," the startup dispensed prescriptions that weren't issued for a legitimate medical purpose, the DEA alleges.
In the past two years, highly funded startups have tried to disrupt mental-health care. The startups said they wanted to help solve the industry's biggest problems: Mental-health care is too expensive, and there isn't enough of it to go around. Talkspace's priority is now its division that sells mental-health care to employers, which pay recurring fees for employee access. Startups tackling more serious mental-health conditions are working with health plansThere's also a rising crop of mental-health companies tackling the costliest mental-health conditions, something the direct-to-consumer firms tend to shy away from. About half of Bicycle's patients pay with their insurance, a number he's looking to increase.
"Amazon Clinic" plays to Amazon's strengths as an ecommerce behemoth. On Tuesday, Amazon announced "Amazon Clinic," a virtual care service that will treat patients' common conditions such as allergies and hair loss. The launch comes just a couple of months after the tech giant said it was shuttering Amazon Care, a telehealth service that provided care through people's employers. By contrast, Amazon Clinic could have more success doing what it knows best, especially if it can lure Prime members. Amazon Clinic.
Former Cerebral CEO Kyle Robertson just notified the company that he may be gearing up for a lawsuit. Robertson was pushed out in May amid concerns about Cerebral's prescribing practices. Called a "books and records" letter, it demands that the company allow Robertson to access information from the mental-health startup's files in preparation for a potential lawsuit. A Cerebral spokesperson said that Robertson's claims are "categorically untrue and baseless in law and in fact." In the letter, Robertson says that he also wants to investigate an improper valuation of the company's stock and allegations that he was discriminated against on the basis of his LGBTQ status.
Google is working on a wearable for preteens in an effort called "Project Eleven." Google is developing a wearable device for preteens under its Fitbit group as it attempts to capture a growing demographic of younger users who own wearable tech, three employees familiar with the project told Insider. Apple in 2021 accounted for about 30% of global wearable shipments, according to the IDC Worldwide Quarterly Wearable Device Tracker. Are you a Google employee with a tip? Are you a Google employee with a tip about health projects?
The embattled startup hired against unprofitable growth, Jess Muse, Cerebral's president, said. Cerebral, she said, paid more money on advertising to bring in new patients than it recouped by providing mental-health services and prescriptions. Prioritizing turning a profitCerebral leaders held a series of staff meetings on Monday. During the Monday staff meetings, at least two employees expressed concerns about the increased workload, since remaining staff are taking on patients of those who were laid off. Several employees accused company leaders of blindsiding workers with layoffs after the employees said they were assured the company was performing well.
Cerebral, the SoftBank-backed mental-health startup, is making changes and cuts that will affect about 20% of its employees, Cerebral CEO Dr. David Mou said in an email to employees, reviewed by Insider. In the October 24 email, Mou said the company was adjusting the size of clinician teams to better match patient demand. Employees will be notified of changes throughout the week, Mou said. "We are deeply appreciative of our employees' commitment to our mission and service to Cerebral," the spokesperson said in the statement. These changes will be spread across all divisions - HQ Operations, HQ Support, Clinical Care - affecting approximately 20% of our employees.
It has plans for another Pixel Watch for 2023 and a new Fitbit fitness tracker. "The Pixel Watch is the highest priority right now," said one current employee. Google hits the reset buttonThe Pixel Watch marks something of a reset in wearables for Google. Google dismantled its own health program, Google Health, in 2021, and has struggled to form a cohesive vision in healthcare. "I struggle to see how it will remain a separate service for Pixel Watch to be honest, as from a brand perspective is not very clean."
Total: 25